Infections with the sexually transmitted protozoan Trichomonas vaginalis are usually treated
with metronidazole, a 5-nitroimidazole drug derived from the antibiotic azomycin …

Innate and adaptive immunity play a significant role in trichomoniasis, the most common non-
viral sexually transmitted disease worldwide. In the urogenital tract, innate immunity is …

Trichomonas vaginalis is a protozoan parasite that causes a widely distributed sexually
transmitted disease (STD). Since immunoglobulin G (IgG) antibodies to specific trichomonad …

Trichomoniasis caused by Trichomonas vaginalis may lead to either a complete absence of
symptoms or to severe inflammatory manifestations in infected women. Studies of the role of …

Trichomoniasis, the most common nonviral sexually transmitted disease, is caused by
infection with the protist Trichomonas vaginalis. The clinical spectrum varies from an …

Trichomoniasis, caused by the protozoan parasite Trichomonas vaginalis, is a major
nonviral sexually transmitted disease. Clinical spectrum varies from an asymptomatic state …

Infection with Trichomonas vaginalis may be asymptomatic or with symptoms suggestive of
vaginitis. Because cysteine proteinase 30 (CP30) of T. vaginalis is known to be a virulence …

Background: Vaginal epithelium is the most important site for initial contact of the parasite
infection in humans. Objective: To investigate the effect of LACTOBACILLUS acidophilus …

Introduction: Human trichomoniasis due to Trichomonas vaginalis is a curable sexually
transmitted infection. It may lead to symptomatic vaginitis or asymptomatic carrier state. The …

A reliable laboratory animal model would be useful for the study of immune responses to
trichomoniasis, a sexually transmitted disease of human beings and cattle. Murine models …